GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » EV-to-FCF

Neurotech International (ASX:NTI) EV-to-FCF : -17.56 (As of May. 18, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Neurotech International's Enterprise Value is A$74.88 Mil. Neurotech International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$-4.27 Mil. Therefore, Neurotech International's EV-to-FCF for today is -17.56.

The historical rank and industry rank for Neurotech International's EV-to-FCF or its related term are showing as below:

ASX:NTI' s EV-to-FCF Range Over the Past 10 Years
Min: -27.22   Med: -8.1   Max: 0.35
Current: -16.6

During the past 7 years, the highest EV-to-FCF of Neurotech International was 0.35. The lowest was -27.22. And the median was -8.10.

ASX:NTI's EV-to-FCF is ranked worse than
100% of 363 companies
in the Medical Devices & Instruments industry
Industry Median: 28.4 vs ASX:NTI: -16.60

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Neurotech International's stock price is A$0.078. Neurotech International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.006. Therefore, Neurotech International's PE Ratio for today is At Loss.


Neurotech International EV-to-FCF Historical Data

The historical data trend for Neurotech International's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International EV-to-FCF Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-FCF
Get a 7-Day Free Trial -0.93 -3.21 -13.86 -15.87 -4.74

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -15.87 - -4.74 -

Competitive Comparison of Neurotech International's EV-to-FCF

For the Medical Devices subindustry, Neurotech International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurotech International's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neurotech International's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Neurotech International's EV-to-FCF falls into.



Neurotech International EV-to-FCF Calculation

Neurotech International's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=74.877/-4.265
=-17.56

Neurotech International's current Enterprise Value is A$74.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Neurotech International's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$-4.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurotech International  (ASX:NTI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Neurotech International's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.078/-0.006
=At Loss

Neurotech International's share price for today is A$0.078.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Neurotech International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.006.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Neurotech International EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Neurotech International's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013